CLX
October 30, 2024 - AI Summary
Undervalued by 170.3% based on the discounted cash flow analysis.
Market cap | $15.07 Billion |
---|---|
Enterprise Value | $17.78 Billion |
Dividend Yield | $4.90 (3.98%) |
Earnings per Share | $6.56 |
Beta | 0.52 |
Outstanding Shares | 123,173,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 18.73 |
---|---|
PEG | 34.88 |
Price to Sales | 2.16 |
Price to Book Ratio | 41.06 |
Enterprise Value to Revenue | 2.5 |
Enterprise Value to EBIT | 10.91 |
Enterprise Value to Net Income | 21 |
Total Debt to Enterprise | 0.16 |
Debt to Equity | 8.97 |
No data
No data
The Clorox Company (NYSE: CLX) is a leading multinational manufacturer and marketer of consumer and professional products with about 8,800 employees worldwide and fiscal year 2020 sales of $6.7 billion. Clorox markets some of the most tr...